The Prognostic Impact of the Lymphocyte-to-Monocyte Ratio in Resected Pancreatic Head Adenocarcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
The Prognostic Impact of the Lymphocyte-to-Monocyte Ratio in Resected Pancreatic Head Adenocarcinoma ; volume:28 ; number:6 ; year:2019 ; pages:517-525
Medical principles and practice ; 28, Heft 6 (2019), 517-525
- Urheber
-
Onoe, Shunsuke
Maeda, Atsuyuki
Takayama, Yuichi
Fukami, Yasuyuki
Takahashi, Takamasa
Uji, Masahito
Kaneoka, Yuji
- DOI
-
10.1159/000501017
- URN
-
urn:nbn:de:101:1-2019121823330335733609
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Onoe, Shunsuke
- Maeda, Atsuyuki
- Takayama, Yuichi
- Fukami, Yasuyuki
- Takahashi, Takamasa
- Uji, Masahito
- Kaneoka, Yuji
Ähnliche Objekte (12)
Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma
A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma
Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer
Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma
Is There a Role for Intraoperative Radiation Therapy in Patients with Resected Pancreatic Adenocarcinoma?
Pancreatic ductal adenocarcinoma with inferior vena cava invasion: a report of three resected cases
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
Platelet/lymphocyte, neutrophil/lymphocyte, and lymphocyte/monocyte ratios as biomarkers for rheumatoid arthritis: correlation with disease activity
Impact of Preoperative Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios on Long-Term Survival in Patients with Operable Pancreatic Ductal Adenocarcinoma
Prognostic impact of circulating tumor DNA detection in portal and peripheral blood in resected pancreatic ductal adenocarcinoma patients
Relationship of neutrophil lymphocyte ratio, monocyte lymphocyte ratio and neutrophil monocyte ratio with treatment response in pulmonary tuberculosis patients during intensive phase treatment
Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma
A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma
Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer
Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma
Is There a Role for Intraoperative Radiation Therapy in Patients with Resected Pancreatic Adenocarcinoma?
Pancreatic ductal adenocarcinoma with inferior vena cava invasion: a report of three resected cases
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
Platelet/lymphocyte, neutrophil/lymphocyte, and lymphocyte/monocyte ratios as biomarkers for rheumatoid arthritis: correlation with disease activity
Impact of Preoperative Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios on Long-Term Survival in Patients with Operable Pancreatic Ductal Adenocarcinoma
Prognostic impact of circulating tumor DNA detection in portal and peripheral blood in resected pancreatic ductal adenocarcinoma patients
Relationship of neutrophil lymphocyte ratio, monocyte lymphocyte ratio and neutrophil monocyte ratio with treatment response in pulmonary tuberculosis patients during intensive phase treatment
Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma
A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma
Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer
Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma
Is There a Role for Intraoperative Radiation Therapy in Patients with Resected Pancreatic Adenocarcinoma?
Pancreatic ductal adenocarcinoma with inferior vena cava invasion: a report of three resected cases
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
Platelet/lymphocyte, neutrophil/lymphocyte, and lymphocyte/monocyte ratios as biomarkers for rheumatoid arthritis: correlation with disease activity
Impact of Preoperative Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios on Long-Term Survival in Patients with Operable Pancreatic Ductal Adenocarcinoma
Prognostic impact of circulating tumor DNA detection in portal and peripheral blood in resected pancreatic ductal adenocarcinoma patients